Thyrocare Technologies Ltd. Earnings/Conference Calls

Thyrocare Technologies Ltd. earnings concalls and investor presentations

Load latest

Thyrocare Technologies Ltd.

07 May 2022

878.10

-1.36%

Earnings Call

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Further to our letter dated 05-05-2022, we wish to inform that the post 2022 financial results conference call with the analysts / investors was held on Friday, the 6th May 2022. The audio recording of the same is available at our website, and can be accessed by using the link provided in the enclosed sheet .

pdf

Thyrocare Technologies Ltd.

30 Apr 2022, 07:39PM

878.10

-1.36%

Investor Presentation

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Presentation on Audited Financial Results for the quarter / whole year ended 31-03-2022

pdf

Thyrocare Technologies Ltd.

12 Feb 2022

878.10

-1.36%

Investor Presentation

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Presentation - Unaudited financial results for the quarter/nine months period ended 31-12-2021.

pdf

Thyrocare Technologies Ltd.

15 Nov 2021

878.10

-1.36%

Investor Presentation

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

We are forwarding a copy of Presentation on Quarterly Results of our company for the quarter / half year ended 30-09-2021.

pdf

Thyrocare Technologies Ltd.

13 Aug 2021

878.10

-1.36%

Investor Presentation

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Forwarding copy of Presentation on Quarterly Results of our company for the quarter ended 30-06-2021.

pdf

Thyrocare Technologies Ltd.

10 May 2021

878.10

-1.36%

Investor Presentation

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Forwarding copy of Presentation on Annual Results of our company for the year ended 31-03-2021.

pdf

Thyrocare Technologies Ltd.

10 May 2021

878.10

-1.36%

Investor Presentation

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Forwarding copy of Presentation on Annual Results of our company for the year ended 31-03-2021.

pdf

Thyrocare Technologies Ltd.

20 Feb 2021

878.10

-1.36%

Earnings Call

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are filing herewith the transcript of the Earnings Call held on Thursday, February 04, 2021 at 05.00 P.M. local time, post declaration of the Company's unaudited financial results (Stand-alone and Consolidated) for Quarter / Nine Months ended December 31, 2020. This transcript is also made available at our website. Dr. A. Velumani, Chairman & Managing Director, Mr. Arindam Haldar, CEO, Mr. A. Sundararaju, CFO & Executive Director, Mr. Sachin Salvi, Vice-President- Finance, represented the Company.

pdf

Thyrocare Technologies Ltd.

05 Feb 2021

878.10

-1.36%

Earnings Call for Q3FY21 of Thyrocare Technologies

Conference Call with Thyrocare Technologies Management and Analysts on Q3FY21 Performance and Outlook. Listen to the full earnings transcript.

Thyrocare Technologies Ltd.

01 Feb 2021, 06:28PM

878.10

-1.36%

Investor Presentation

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

We are forwarding a copy of Presentation on Quarterly Results of our company for the quarter / nine months ended 31-12-2020. Please note that this is only uploaded in our website, and has not been distributed or advertised in newspapers or otherwise publicised.

pdf